Catalyst Pharmaceuticals (CPRX) Return on Invested Capital: 2020-2025
Historic Return on Invested Capital for Catalyst Pharmaceuticals (CPRX) over the last 4 years, with Sep 2025 value amounting to 0.22%.
- Catalyst Pharmaceuticals' Return on Invested Capital rose 3.00% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 3.00%. This contributed to the annual value of 0.26% for FY2024, which is 11.00% up from last year.
- Latest data reveals that Catalyst Pharmaceuticals reported Return on Invested Capital of 0.22% as of Q3 2025, which was down 1.99% from 0.23% recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' Return on Invested Capital registered a high of 0.31% during Q2 2023, and its lowest value of 0.09% during Q2 2024.
- Moreover, its 3-year median value for Return on Invested Capital was 0.21% (2024), whereas its average is 0.20%.
- Per our database at Business Quant, Catalyst Pharmaceuticals' Return on Invested Capital dropped by 22bps in 2024 and then grew by 14bps in 2025.
- Over the past 5 years, Catalyst Pharmaceuticals' Return on Invested Capital (Quarterly) stood at 0.19% in 2021, then grew by 9bps to 0.28% in 2022, then dropped by 13bps to 0.15% in 2023, then grew by 6bps to 0.21% in 2024, then rose by 3bps to 0.22% in 2025.
- Its last three reported values are 0.22% in Q3 2025, 0.23% for Q2 2025, and 0.23% during Q1 2025.